Molecular Refinement of Clinical Staging in Hepatocellular Carcinoma Patients Evaluated for Potentially Curative Therapies
Table 4
Evaluation of the independent contribution of each variable to Cox Proportional Hazard Model. Multivariate Survival Analysis using AFP mRNA and VEGF as an integrated variable.